李楠于北京协和医学院获得生药学专业博士学位，于2023年加入GMU iCAN Lab，开展博士后研究工作。她专门从事纳米生物材料与临床转化研究，主要专注于研究生物材料免疫调控能力。目前项目集中在建立可调控免疫微环境的生物医学植入物。她的研究旨在为肿瘤免疫疾病治疗提供创新解决方案。
Nan Li obtained her Doctor's degree in Pharmacognosy from Peking Union Medical College. She joined the iCAN Lab at GMU in 2023 to conduct postdoctoral research. She specializes in the research of nanobiomaterials and their clinical translation, with a primary focus on investigating the immunomodulatory capabilities of biomaterials. Her current projects center on the development of biomedical implants capable of regulating the immune microenvironment. Her research aims to provide innovative solutions for the treatment of tumors and immune-related diseases.